Name | Pulocimab |
---|
Description | Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb). Pulocimab can be used for the research of cancers[1]. |
---|---|
Related Catalog | |
Target |
VEGFR2 |
References |
[1]. Keam SJ. Cadonilimab: First Approval. Drugs. 2022 Aug;82(12):1333-1339. |
No Any Chemical & Physical Properties |